Detection of extended-spectrum beta-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes
- PMID: 10655342
- PMCID: PMC86144
- DOI: 10.1128/JCM.38.2.542-546.2000
Detection of extended-spectrum beta-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes
Abstract
The aim of the present study was to investigate the frequency of extended-spectrum beta-lactamases (ESBLs) in a consecutive collection of clinical isolates of Enterobacter spp. The abilities of various screening methods to detect ESBLs in enterobacters were simultaneously tested. Among the 68 consecutive isolates (56 Enterobacter cloacae and 12 Enterobacter aerogenes isolates) that were analyzed for beta-lactamase content, 21 (25 and 58%, respectively) possessed transferable ESBLs with pIs of 8.2 and phenotypic characteristics of SHV-type enzymes, 8 (14.3%) of the E. cloacae isolates produced a previously nondescribed, clavulanate-susceptible ESBL that exhibited a pI of 6.9 and that conferred a ceftazidime resistance phenotype on Escherichia coli transconjugants, and 2 E. cloacae isolates produced both of these enzymes. Among the total of 31 isolates that were considered ESBL producers, the Vitek ESBL detection test was positive for 2 (6.5%) strains, and the conventional double-disk synergy test (DDST) with amoxicillin-clavulanate and with expanded-spectrum cephalosporins and aztreonam was positive for 5 (16%) strains. Modifications of the DDST consisting of closer application of the disks (at 20 instead of 30 mm), the use of cefepime, and the use of both modifications increased the sensitivity of this test to 71, 61, and 90%, respectively. Of the 37 isolates for which isoelectric focusing failed to determine ESBLs, the Vitek test was false positive for 1 isolate and the various forms of DDSTs were false-positive for 3 isolates.
Figures
Similar articles
-
Epidemiology of extended-spectrum beta-lactamase-producing Enterobacter isolates in a Spanish hospital during a 12-year period.J Clin Microbiol. 2002 Apr;40(4):1237-43. doi: 10.1128/JCM.40.4.1237-1243.2002. J Clin Microbiol. 2002. PMID: 11923338 Free PMC article.
-
Screening extended-spectrum beta-lactamase production in Enterobacter cloacae and Serratia marcescens using antibiogram-based methods.J Microbiol Immunol Infect. 2010 Feb;43(1):26-34. doi: 10.1016/S1684-1182(10)60004-7. Epub 2010 Mar 29. J Microbiol Immunol Infect. 2010. PMID: 20434120
-
Prevalence of extended-spectrum beta-lactamases in Enterobacter cloacae in Taiwan and comparison of 3 phenotypic confirmatory methods for detecting extended-spectrum beta-lactamase production.J Microbiol Immunol Infect. 2009 Aug;42(4):310-6. J Microbiol Immunol Infect. 2009. PMID: 19949754
-
Antibiotic resistance in Enterobacter hormaechei.Int J Antimicrob Agents. 2022 Oct;60(4):106650. doi: 10.1016/j.ijantimicag.2022.106650. Epub 2022 Aug 4. Int J Antimicrob Agents. 2022. PMID: 35934231 Review.
-
Extended Spectrum Beta-lactamases: Definition, Classification and Epidemiology.Curr Issues Mol Biol. 2015;17:11-21. Epub 2014 May 12. Curr Issues Mol Biol. 2015. PMID: 24821872 Review.
Cited by
-
Antimicrobial resistance and AmpC production in ESBL-producing Klebsiella pneumoniae and Klebsiella quasipneumoniae: A retrospective study in Japanese clinical isolates.PLoS One. 2024 May 14;19(5):e0303353. doi: 10.1371/journal.pone.0303353. eCollection 2024. PLoS One. 2024. PMID: 38743684 Free PMC article.
-
CTX-M, TEM, and SHV Genes in Escherichia coli, Klebsiella pneumoniae, and Enterobacter spp Isolated from Hematologic Cancer Patients with Bacteremia in Uganda.Infect Drug Resist. 2024 Feb 16;17:641-653. doi: 10.2147/IDR.S442646. eCollection 2024. Infect Drug Resist. 2024. PMID: 38384499 Free PMC article.
-
Evaluation of antimicrobial susceptibility tests for Acinetobacter and Pseudomonas species using disks containing a high dose of meropenem.Sci Rep. 2024 Feb 2;14(1):2749. doi: 10.1038/s41598-024-52538-x. Sci Rep. 2024. PMID: 38302510 Free PMC article.
-
Phenotypic characterization and epidemiology of extended-spectrum β-lactamase-producing Enterobacteriaceae strains from urinary tract infections in Garoua, Cameroon.Front Public Health. 2023 Jun 29;11:1187934. doi: 10.3389/fpubh.2023.1187934. eCollection 2023. Front Public Health. 2023. PMID: 37457273 Free PMC article.
-
Study of Plasmid-Mediated Extended-Spectrum Beta-Lactamase-Producing Clinical Strains of Enterobacteriaceae From Tabuk Region.Cureus. 2023 Jun 9;15(6):e40183. doi: 10.7759/cureus.40183. eCollection 2023 Jun. Cureus. 2023. PMID: 37431354 Free PMC article.
References
-
- Bush K. Is it important to identify extended-spectrum beta-lactamase-producing isolates? Eur J Clin Microbiol Infect Dis. 1996;15:361–364. - PubMed
-
- Chanal C, Sirot D, Romaszko J P, Bret L, Sirot J. Survey of extended-spectrum β-lactamases among Enterobacteriaceae. J Antimicrob Chemother. 1996;38:127–132. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous